GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Beijing Chunlizhengda Medical Instruments Co Ltd (HKSE:01858) » Definitions » Beneish M-Score

Beijing Chunlizhengda Medical Instruments Co (HKSE:01858) Beneish M-Score : -3.16 (As of May. 31, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Beijing Chunlizhengda Medical Instruments Co Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -3.16 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Beijing Chunlizhengda Medical Instruments Co's Beneish M-Score or its related term are showing as below:

HKSE:01858' s Beneish M-Score Range Over the Past 10 Years
Min: -3.16   Med: -2.05   Max: -1.66
Current: -3.16

During the past 11 years, the highest Beneish M-Score of Beijing Chunlizhengda Medical Instruments Co was -1.66. The lowest was -3.16. And the median was -2.05.


Beijing Chunlizhengda Medical Instruments Co Beneish M-Score Historical Data

The historical data trend for Beijing Chunlizhengda Medical Instruments Co's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Chunlizhengda Medical Instruments Co Beneish M-Score Chart

Beijing Chunlizhengda Medical Instruments Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.66 -2.05 -1.78 -1.94 -3.16

Beijing Chunlizhengda Medical Instruments Co Quarterly Data
Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Sep22 Dec22 Jun23 Sep23 Dec23 Mar24
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.94 - - -3.16 -

Competitive Comparison of Beijing Chunlizhengda Medical Instruments Co's Beneish M-Score

For the Medical Devices subindustry, Beijing Chunlizhengda Medical Instruments Co's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Beijing Chunlizhengda Medical Instruments Co's Beneish M-Score Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Beijing Chunlizhengda Medical Instruments Co's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Beijing Chunlizhengda Medical Instruments Co's Beneish M-Score falls into.



Beijing Chunlizhengda Medical Instruments Co Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Beijing Chunlizhengda Medical Instruments Co for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * +0.528 * +0.404 * +0.892 * +0.115 *
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * +4.679 * -0.327 *
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Sep22) TTM:
Total Receivables was HK$503.5 Mil.
Revenue was 455.415 + 269.731 + 0 + 493.186 = HK$1,218.3 Mil.
Gross Profit was 345.748 + 180.62 + 0 + 393.126 = HK$919.5 Mil.
Total Current Assets was HK$3,287.2 Mil.
Total Assets was HK$3,991.8 Mil.
Property, Plant and Equipment(Net PPE) was HK$508.8 Mil.
Depreciation, Depletion and Amortization(DDA) was HK$0.0 Mil.
Selling, General, & Admin. Expense(SGA) was HK$356.9 Mil.
Total Current Liabilities was HK$740.1 Mil.
Long-Term Debt & Capital Lease Obligation was HK$0.6 Mil.
Net Income was 106.31 + 58.611 + 0 + 109.451 = HK$274.4 Mil.
Non Operating Income was 0 + 0 + 0 + 0 = HK$0.0 Mil.
Cash Flow from Operations was 0 + 0 + 0 + 0 = HK$0.0 Mil.
Total Receivables was HK$0.0 Mil.
Revenue was 210.868 + 0 + 0 + 0 = HK$210.9 Mil.
Gross Profit was 151.733 + 0 + 0 + 0 = HK$151.7 Mil.
Total Current Assets was HK$0.0 Mil.
Total Assets was HK$0.0 Mil.
Property, Plant and Equipment(Net PPE) was HK$0.0 Mil.
Depreciation, Depletion and Amortization(DDA) was HK$0.0 Mil.
Selling, General, & Admin. Expense(SGA) was HK$140.1 Mil.
Total Current Liabilities was HK$0.0 Mil.
Long-Term Debt & Capital Lease Obligation was HK$0.0 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(503.499 / 1218.332) / (0 / 210.868)
=0.413269 / 0
=

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(151.733 / 210.868) / (919.494 / 1218.332)
=0.719564 / 0.754715
=

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (3287.199 + 508.755) / 3991.813) / (1 - (0 + 0) / 0)
=0.049065 /
=

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=1218.332 / 210.868
=

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(0 / (0 + 0)) / (0 / (0 + 508.755))
= / 0
=

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(356.852 / 1218.332) / (140.075 / 210.868)
=0.292902 / 0.664278
=

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((0.582 + 740.131) / 3991.813) / ((0 + 0) / 0)
=0.185558 /
=

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(274.372 - 0 - 0) / 3991.813
=0.068734

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.


Beijing Chunlizhengda Medical Instruments Co Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Beijing Chunlizhengda Medical Instruments Co's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Beijing Chunlizhengda Medical Instruments Co (HKSE:01858) Business Description

Traded in Other Exchanges
Address
No. 10 Xinmi Xi Er Road, Southern District of Tongzhou, Economic Development Zone, Tongzhou District, Beijing, CHN
Beijing Chunlizhengda Medical Instruments Co Ltd is an orthopedic medical device company. It is engaged in the research, development, manufacture, and sale of orthopedic medical devices, including joint prosthesis products and spinal products. The products offered by the company are classified into three categories, namely Standard joint prosthesis products, Custom joint prosthesis products, and Spinal products. It operates in the business segment of manufacture and trading of surgical implants, instruments and related products.
Executives
Fil Limited 2201 Interest of corporation controlled by you
Pandanus Associates Inc. 2201 Interest of corporation controlled by you
Pandanus Partners L.p. 2201 Interest of corporation controlled by you
Brown Brothers Harriman & Co. 2502 Approved lending agent
Citigroup Inc. 2502 Approved lending agent
Fidelity China Special Situations Plc 2101 Beneficial owner
Taiping Assets Management (hk) Company Limited 2102 Investment manager
Taiping Trustees Limited 2301 Trustee

Beijing Chunlizhengda Medical Instruments Co (HKSE:01858) Headlines

No Headlines